STAT October 4, 2023
Lev Facher

No medication is approved to treat addiction to either methamphetamine or cocaine. But the Food and Drug Administration is taking steps to fill that glaring gap in addiction medicine.

The agency on Wednesday issued draft guidance that encourages drug manufacturers to develop new treatments that could help treat addiction to meth, cocaine, or prescription stimulants. While the country’s current drug overdose crisis is largely driven by opioids, stimulant use has skyrocketed in recent years. An increasing share of drug deaths are now attributed to a combination of opioids and stimulants, or, in some cases, stimulants alone.

The FDA’s move comes amid increased recognition of the threat posed by stimulants, and the continued lack of medication options available for health...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

 
Topics: FDA, Govt Agencies, Mental Health, Provider
The telehealth background of Trump's FDA pick: 6 notes
President-elect Trump's picks for CDC, FDA, surgeon general: 31 notes
Opinion: RFK Jr. and MAHA should champion a Marshall Plan for obesity
Trump picks Johns Hopkins surgeon to head FDA: 10 things to know
Regulatory Hurdles and Ethical Concerns Beset FDA Oversight of AI/ML Devices

Share This Article